Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors
Ghazaly E., Woodcock V., Spilipoulou P., Spiers L., Moschandreas J., Griffiths L., Gnanaranjan C., Harrison DJ., Evans TRJ., Blagden S.